Comparison between Ospyn Technologies IPO and Speciality Medicines IPO.
Ospyn Technologies IPO is a SME Bookbuilding IPO proposed to list at BSE SME while Speciality Medicines IPO is a SME Bookbuilding proposed to list at BSE SME.
Ospyn Technologies IPO | Speciality Medicines IPO | |
---|---|---|
Logo | ![]() | ![]() |
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Bookbuilding | Bookbuilding |
Listing At | BSE SME | BSE SME |
Lead Managers | GYR Capital Advisors Pvt.Ltd. | Ekadrisht Capital Pvt.Ltd. |
Registrar | Kfin Technologies Ltd. | Skyline Financial Services Pvt.Ltd. |
Market Maker | ||
DRHP | DRHP ![]() | DRHP ![]() |
RHP | RHP ![]() | RHP ![]() |
Anchor Investor | ||
IPO Allotment URL |
The total issue size of Ospyn Technologies IPO is up to ₹0.00 Cr whereas the issue size of the Speciality Medicines IPO is up to ₹0.00 Cr. The final issue price of Ospyn Technologies IPO is and of Speciality Medicines IPO is .
Ospyn Technologies IPO | Speciality Medicines IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ||
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | ||
Fresh Issue Size | 55,00,000 shares | 23,00,000 shares |
Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
OFS Issue Size | 0 shares | 0 shares |
OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Issue Size Total | 55,00,000 shares | 23,00,000 shares |
Issue Size Total (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
Ospyn Technologies IPO opens on , while Speciality Medicines IPO opens on . The closing date of Ospyn Technologies IPO and Speciality Medicines IPO is , and , respectively.
Ospyn Technologies IPO | Speciality Medicines IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | ||
Issue Close | ||
Basis Of Allotment (Tentative) | ||
Initiation of Refunds (Tentative) | ||
Credit of Share (Tentative) | ||
Listing date (Tentative) | ||
Anchor Lockin End date 1 | ||
Anchor Lockin End date 2 |
Ospyn Technologies IPO P/E ratio is , as compared to Speciality Medicines IPO P/E ratio of .
Ospyn Technologies IPO | Speciality Medicines IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financials | Ospyn Technologies Limited Financial Information (Restated Consolidated)
| Speciality Medicines Limited Financial Information (Restated)
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 94.80 | 62.70 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | 40.44% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | 34.95% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | 0.33 | 0.17 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ₹7.06 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW | 27.42% | 27.36% |
In the Ospyn Technologies IPO Retail Individual Investors (RII) are offered while in Speciality Medicines IPO retail investors are offered . Qualified Institutional Buyers (QIB) are offered in Ospyn Technologies IPO and in Speciality Medicines IPO.
Ospyn Technologies IPO | Speciality Medicines IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | ||
NII | ||
RII | ||
Employee | ||
Others | ||
Total |
Ospyn Technologies IPO subscribed in total, whereas Speciality Medicines IPO subscribed .
Ospyn Technologies IPO | Speciality Medicines IPO | |
---|---|---|
QIB (times) | ||
NII (times) | ||
Big NII (times) | ||
Small NII (times) | ||
RII (times) | ||
Employee (times) | ||
Other (times) | ||
Total (times) |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O